Siren, L.L.C.
An institutional investment manager in New York, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 13, 2026. SEC CIK 2005245.
- Reported value$4.94bn
- Positions117
Holdings: 117 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31. The filing's table has 119 lines; lines for the same security and option type are added together here.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Scholar Rock Holding CorpSRRK | COM | 80706P103 | 527 | 10.7% | 9,575,013 | Reduced−1,250,000 | |
| Kymera Therapeutics IncKYMR | COM | 501575104 | 337 | 6.8% | 2,935,830 | Reduced−251,000 | |
| Erasca IncERAS | COM | 29479A108 | 209 | 4.2% | 11,397,781 | Added+153,535 | |
| Veradermics IncMANE | COMMON STOCK | 922967104 | 204 | 4.1% | 1,655,374 | Added+150,000 | |
| Tango Therapeutics IncTNGX | COM | 87583X109 | 193 | 3.9% | 6,179,364 | Added+522,259 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 169 | 3.4% | 900,000 | Reduced−210,980 | |
| Bicara Therapeutics IncBCAX | COM | 055477103 | 166 | 3.4% | 5,602,970 | Reduced−200,000 | |
| Arrowhead Pharmaceuticals IncARWR | COM | 04280A100 | 140 | 2.8% | 1,715,476 | Added+100,000 | |
| BeOne Medicines AGONC | SPONSORED ADS | 07725L102 | 133 | 2.7% | 465,000 | Unchanged | |
| Edgewise Therapeutics IncEWTX | COM | 28036F105 | 129 | 2.6% | 3,184,629 | Reduced−1,245,634 | |
| Rhythm Pharmaceuticals IncRYTM | COM | 76243J105 | 126 | 2.6% | 1,136,275 | Added+410,764 | |
| Lexicon Pharmaceuticals IncLXRX | COM NEW | 528872302 | 106 | 2.2% | 44,303,518 | Unchanged | |
| Enliven Therapeutics IncELVN | COM | 29337E102 | 90.1 | 1.8% | 1,774,411 | Added+1,028,185 | |
| Spyre Therapeutics IncSYRE | COM NEW | 00773J202 | 86.0 | 1.7% | 968,598 | Added+150,000 | |
| Parabilis Medicines IncPBLS | COM | 698955101 | 81.9 | 1.7% | 2,992,259 | New+2,992,259 | |
| Xenon Pharmaceuticals IncXENE | COM | 98420N105 | 79.6 | 1.6% | 1,318,564 | Unchanged | |
| Solid Biosciences IncSLDB | COM NEW | 83422E204 | 76.8 | 1.6% | 7,690,405 | Unchanged | |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 76.8 | 1.6% | 576,000 | New+576,000 | |
| Hemab Therapeutics Holdings IncCOAG | COM SHS | 423494103 | 76.6 | 1.6% | 2,086,834 | New+2,086,834 | |
| Arcus Biosciences IncRCUS | COM | 03969F109 | 74.6 | 1.5% | 2,420,430 | Reduced−586,647 | |
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 72.0 | 1.5% | 1,859,279 | Added+150,000 | |
| Relay Therapeutics IncRLAY | COM | 75943R102 | 68.3 | 1.4% | 3,650,000 | New+3,650,000 | |
| Taysha Gene Therapies IncTSHA | COM SHS | 877619106 | 67.1 | 1.4% | 9,846,579 | Added+1,016,666 | |
| Definium Therapeutics IncDFTX | COM SHS | 24477V105 | 66.8 | 1.4% | 1,419,493 | Added+500,000 | |
| Stoke Therapeutics IncSTOK | COM | 86150R107 | 65.3 | 1.3% | 1,995,347 | Unchanged | |
| Disc Medicine IncIRON | COM | 254604101 | 65.0 | 1.3% | 888,401 | Reduced−100,000 | |
| Cytokinetics IncCYTK | COM NEW | 23282W605 | 64.7 | 1.3% | 758,952 | Added+145,000 | |
| Septerna IncSEPN | COM | 81734D104 | 63.6 | 1.3% | 1,900,000 | Reduced−100,000 | |
| Olema Pharmaceuticals IncOLMA | COM | 68062P106 | 60.8 | 1.2% | 4,856,949 | Added+100,000 | |
| Crinetics Pharmaceuticals Inc | COM | 22663K107 | 53.2 | 1.1% | 1,420,788 | Reduced−482,848 | |
| Kailera Therapeutics IncKLRA | COMMON STOCK | 482931102 | 48.8 | 1.0% | 2,214,286 | New+2,214,286 | |
| Dyne Therapeutics, IncDYN | COM | 26818M108 | 47.3 | 1.0% | 2,129,125 | Reduced−100,000 | |
| Structure Therapeutics IncGPCR | SPONSORED ADS | 86366E106 | 46.9 | 0.9% | 872,967 | Reduced−455,731 | |
| Taboola.com Ltd | ORD SHS | M8744T106 | 42.1 | 0.9% | 8,423,410 | Reduced−1,546,085 | |
| Palvella Therapeutics IncPVLA | COM | 697947109 | 39.3 | 0.8% | 257,485 | Unchanged | |
| Silence Therapeutics PLCSLN | ADS | 82686Q101 | 36.4 | 0.7% | 3,311,438 | Added+400,000 | |
| Denali Therapeutics IncDNLI | COM | 24823R105 | 35.9 | 0.7% | 1,396,513 | Unchanged | |
| Remitly Global IncRELY | COM | 75960P104 | 34.6 | 0.7% | 1,543,271 | Unchanged | |
| Cullinan Therapeutics IncCGEM | COM | 230031106 | 34.5 | 0.7% | 1,893,410 | Added+700,000 | |
| Capital One Finl CorpCOF | COM | 14040H105 | 34.4 | 0.7% | 171,615 | New+171,615 | |
| Trevi Therapeutics IncTRVI | COM | 89532M101 | 33.3 | 0.7% | 1,786,867 | Unchanged | |
| Oric Pharmaceuticals IncORIC | COM | 68622P109 | 32.5 | 0.7% | 2,998,192 | Unchanged | |
| Alphabet IncGOOGL | CAP STK CL A | 02079K305 | 32.2 | 0.7% | 90,000 | Added+24,297 | |
| Dbv Technologies SADBVT | SPONSORED ADS | 23306J309 | 30.5 | 0.6% | 1,857,362 | Unchanged | |
| Absci CorpABSI | COM | 00091E109 | 28.7 | 0.6% | 2,474,764 | Added+674,764 | |
| Sionna Therapeutics IncSION | COM | 829401108 | 26.9 | 0.5% | 610,515 | Added+310,515 | |
| Rapport Therapeutics IncRAPP | COM | 75383L102 | 26.7 | 0.5% | 641,469 | Unchanged | |
| Amylyx Pharmaceuticals IncAMLX | COM | 03237H101 | 26.6 | 0.5% | 1,480,586 | Added+250,586 | |
| Annexon IncANNX | COM | 03589W102 | 25.5 | 0.5% | 4,458,646 | Added+500,000 | |
| Monopar Therapeutics IncMNPR | COM NEW | 61023L207 | 25.0 | 0.5% | 270,118 | Unchanged | |
| Oruka Therapeutics IncORKA | COM | 687604108 | 23.8 | 0.5% | 250,000 | New+250,000 | |
| Seaport Therapeutics IncSPTX | COMMON STOCK | 81221K108 | 23.8 | 0.5% | 1,095,316 | New+1,095,316 | |
| Damora Therapeutics Inc | COM NEW | 36322Q206 | 23.4 | 0.5% | 900,000 | Unchanged | |
| Tyra Biosciences IncTYRA | COM | 90240B106 | 23.2 | 0.5% | 725,000 | New+725,000 | |
| Zura Bio Ltd | CLASS A ORD SHS | G9TY5A101 | 22.0 | 0.4% | 3,734,866 | Unchanged | |
| Taiwan Semiconductor Manufacturing Co LtdTSM | SPONSORED ADS | 874039100 | 21.3 | 0.4% | 44,700 | Added+2,500 | |
| NVIDIA CorpNVDA | COM | 67066G104 | 19.0 | 0.4% | 95,000 | Added+5,915 | |
| Rezolute IncRZLT | COM NEW | 76200L309 | 17.3 | 0.4% | 3,328,287 | Unchanged | |
| MapLight Therapeutics IncMPLT | COM | 56565P103 | 16.1 | 0.3% | 450,000 | Unchanged | |
| Neumora Therapeutics IncNMRA | COM | 640979100 | 14.4 | 0.3% | 8,497,822 | Unchanged | |
| Nebius Group NV | SHS CLASS A | N97284108 | 14.4 | 0.3% | 52,000 | Reduced−61,614 | |
| Microsoft CorpMSFT | COM | 594918104 | 14.0 | 0.3% | 37,500 | Reduced−3,880 | |
| CytomX Therapeutics IncCTMX | COM | 23284F105 | 13.0 | 0.3% | 3,457,711 | Unchanged | |
| Generate Biomedicines IncGENB | COM SHS | 370920100 | 12.4 | 0.3% | 736,104 | Unchanged | |
| Inhibikase Therapeutics IncIKT | COM NEW | 45719W205 | 11.9 | 0.2% | 5,850,000 | Unchanged | |
| Adagene IncADAG | ADS | 005329107 | 11.2 | 0.2% | 2,666,666 | New+2,666,666 | |
| enGene Therapeutics IncENGN | COM | 29286X101 | 10.8 | 0.2% | 6,256,662 | New+6,256,662 | |
| Whitehawk Therapeutics IncWHWK | COM | 00032Q104 | 10.7 | 0.2% | 2,337,102 | Added+255,102 | |
| Datadog IncDDOG | CL A COM | 23804L103 | 10.4 | 0.2% | 40,000 | Reduced−14,300 | |
| ServiceNow IncNOW | COM | 81762P102 | 9.9 | 0.2% | 100,000 | Added+12,910 | |
| Broadcom IncAVGO | COM | 11135F101 | 9.4 | 0.2% | 25,000 | Added+10,000 | |
| IONQ IncIONQ | COM | 46222L108 | 9.1 | 0.2% | 170,000 | Unchanged | |
| Microsoft CorpMSFT | COM | 594918104 | 9.0 | 0.2% | 24,000 | Call | New+24,000 |
| Jfrog Ltd | ORD SHS | M6191J100 | 8.7 | 0.2% | 95,500 | Reduced−33,316 | |
| Oculis Holding AG | ORDINARY SHARES | H5870P102 | 8.7 | 0.2% | 625,000 | New+625,000 | |
| IREN Ltd | ORDINARY SHARES | Q4982L109 | 8.0 | 0.2% | 175,000 | Added+131,900 | |
| Amazon.com IncAMZN | COM | 023135106 | 7.7 | 0.2% | 32,500 | Reduced−14,141 | |
| CrowdStrike Holdings IncCRWD | CL A | 22788C105 | 7.6 | 0.2% | 10,000 | Reduced−13,070 | |
| Design Therapeutics IncDSGN | COM | 25056L103 | 7.6 | 0.2% | 523,212 | New+523,212 | |
| PDD Holdings IncPDD | SPONSORED ADS | 722304102 | 7.2 | 0.1% | 95,000 | Added+11,599 | |
| Satellos Bioscience IncMSLE | COM | 80401L803 | 6.9 | 0.1% | 892,074 | Unchanged | |
| Dynatrace, IncDT | COM NEW | 268150109 | 6.8 | 0.1% | 155,000 | Added+5,000 | |
| Apple IncAAPL | COM | 037833100 | 6.7 | 0.1% | 23,000 | Call | New+23,000 |
| Tenax Therapeutics IncTENX | COM NEW | 88032L605 | 6.2 | 0.1% | 427,141 | Unchanged | |
| vTv Therapeutics IncVTVT | CL A NEW | 918385204 | 6.1 | 0.1% | 163,000 | Unchanged | |
| Eloxx Pharmaceuticals IncELOX | COM NEW | 29014R301 | 5.6 | 0.1% | 400,000 | New+400,000 | |
| Agomab Therapeutics NVAGMB | SPONSORED ADS | 00860C102 | 5.3 | 0.1% | 411,250 | Unchanged | |
| Alibaba Group Holding LtdBABA | SPONSORED ADS | 01609W102 | 4.8 | <0.1% | 50,000 | New+50,000 | |
| Korro Bio IncKRRO | COM | 500946108 | 4.6 | <0.1% | 347,718 | Unchanged | |
| Cellebrite DI Ltd | ORDINARY SHARES | M2197Q107 | 4.5 | <0.1% | 311,544 | Unchanged | |
| Invivyd IncIVVD | COM | 00534A102 | 4.4 | <0.1% | 5,000,000 | Added+1,000,000 | |
| Ouster IncOUST | COM NEW | 68989M202 | 4.2 | <0.1% | 67,500 | New+67,500 | |
| Palisade Bio IncPALI | COM | 696389402 | 4.2 | <0.1% | 2,000,000 | New+2,000,000 | |
| Aeva Technologies IncAEVA | COM NEW | 00835Q202 | 4.2 | <0.1% | 145,459 | Added+35,459 | |
| Seer IncSEER | COM CL A | 81578P106 | 4.1 | <0.1% | 2,458,673 | Unchanged | |
| NovaBridge BiosciencesNBP | SPONSORED ADS | 44975P103 | 3.9 | <0.1% | 2,004,739 | Reduced−995,261 | |
| GitLab IncGTLB | CLASS A COM | 37637K108 | 3.8 | <0.1% | 125,000 | Added+25,000 | |
| Odyssey Therapeutics IncODTX | COMMON STOCK | 67613T104 | 3.7 | <0.1% | 200,000 | New+200,000 | |
| Foghorn Therapeutics IncFHTX | COM | 344174107 | 3.5 | <0.1% | 720,720 | Unchanged | |
| Agenus IncAGEN | COM NEW | 00847G804 | 3.3 | <0.1% | 1,064,250 | Unchanged | |
| monday.com Ltd | SHS | M7S64H106 | 3.1 | <0.1% | 42,500 | Added+17,500 | |
| Zoetis IncZTS | CL A | 98978V103 | 2.5 | <0.1% | 35,000 | New+35,000 | |
| Workiva IncWK | COM CL A | 98139A105 | 2.2 | <0.1% | 45,000 | Reduced−47,500 | |
| Netflix IncNFLX | COM | 64110L106 | 1.8 | <0.1% | 25,000 | New+25,000 | |
| Kalaris Therapeutics IncKLRS | COM | 482929106 | 1.8 | <0.1% | 435,798 | Unchanged | |
| Quantinuum IncQNT | CL A COM | 74768A104 | 1.6 | <0.1% | 20,000 | New+20,000 | |
| Rani Therapeutics Holdings IncRANI | COM CL A | 753018100 | 1.5 | <0.1% | 2,000,000 | Unchanged | |
| Tesla IncTSLA | COM | 88160R101 | 1.5 | <0.1% | 3,500 | Reduced−18,000 | |
| KE Holdings IncBEKE | SPONSORED ADS | 482497104 | 1.5 | <0.1% | 100,000 | Unchanged | |
| Entera Bio Ltd | SHS | M40527109 | 1.3 | <0.1% | 736,457 | New+736,457 | |
| Medline IncMDLN | COM CL A | 58507V107 | 1.0 | <0.1% | 25,000 | Unchanged | |
| Lumentum Holdings IncLITE | COM | 55024U109 | 0.9 | <0.1% | 1,055 | New+1,055 | |
| Figma IncFIG | CLASS A COM STK | 316841105 | 0.9 | <0.1% | 50,000 | Unchanged | |
| Gossamer Bio Inc | COM | 38341P102 | 0.9 | <0.1% | 5,208,968 | Unchanged | |
| Fox CorpFOXA | CL A COM | 35137L105 | 0.5 | <0.1% | 10,000 | New+10,000 | |
| AT&T IncT | COM | 00206R102 | 0.5 | <0.1% | 25,000 | New+25,000 | |
| Nu Holdings Ltd. | ORD SHS CL A | G6683N103 | 0.3 | <0.1% | 25,000 | Unchanged |
Sold out: 10 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Amer Sports Inc | COM SHS | G0260P102 | 0.0 | 0.0% | 0 | Sold out−50,000 | |
| Bicycle Therapeutics PLCBCYC | SPONSORED ADS | 088786108 | 0.0 | 0.0% | 0 | Sold out−1,560,882 | |
| Centessa Pharmaceuticals PLC | SPONSORED ADS | 152309100 | 0.0 | 0.0% | 0 | Sold out−1,053,464 | |
| enGene Holdings Inc | COM | 29286M105 | 0.0 | 0.0% | 0 | Sold out−5,253,159 | |
| Forgent Power Solutions, IncFPS | COM SHS CL A | 34631F102 | 0.0 | 0.0% | 0 | Sold out−100,000 | |
| Fulcrum Therapeutics IncFULC | COM | 359616109 | 0.0 | 0.0% | 0 | Sold out−2,350,000 | |
| Micron Technology IncMU | COM | 595112103 | 0.0 | 0.0% | 0 | Sold out−6,000 | |
| Primo Brands CorpPRMB | CLASS A COM SHS | 741623102 | 0.0 | 0.0% | 0 | Sold out−50,000 | |
| Uniqure NV | SHS | N90064101 | 0.0 | 0.0% | 0 | Sold out−1,000,000 | |
| WAVE Life Sciences Ltd | SHS | Y95308105 | 0.0 | 0.0% | 0 | Sold out−2,450,000 |
Source: SEC EDGAR, Form 13F-HR, accession 0002005245-26-000008 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.